Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of type 2 diabetes. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://qasimjksz050261.bloggactif.com/40412892/semaglutide-a-potential-solution-for-diabetes